<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ONTY</title>
    <link />
    <description>Headlines for Oncothyreon, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Data on Merck KGaA's L-BLP25  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99962/data-on-merck-kgaas-l-blp25.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 22 May 2013 22:00:01 GMT</pubDate>
    </item>
    <item>
      <title>5 of Last Week's Biggest Losers</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/5-of-last-weeks-biggest-losers-37/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 07:15:00 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/this-week-in-biotech-27/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 13:45:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Horrendous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/3-horrendous-health-care-stocks-this-week-28/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 08:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Oncothyreon A Speculative Buy</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1444841-oncothyreon-a-speculative-buy.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 17 May 2013 20:52:23 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Wedbush Upgrades Oncothyreon on Statistically Significant Overall Survival Benefit</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/05/3600608/update-wedbush-upgrades-oncothyreon-on-statistically-sig.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 17 May 2013 13:45:06 GMT</pubDate>
    </item>
    <item>
      <title>Cancer Drug Drama Rocks 2 Biotech Stocks</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/16/cancer-drug-drama-rocks-2-biotechs/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 16 May 2013 19:32:00 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Morning Market Update: Housing Starts Plummet, Initial Jobless Claims Rise</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/05/3596611/mid-morning-market-update-housing-starts-plummet-initial-jobless-claims-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 16 May 2013 10:51:33 GMT</pubDate>
    </item>
    <item>
      <title>ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11923640/1/asco-13-preview-oncothyreons-failed-lung-cancer-vaccine.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Oncothyreon Inc Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1421631-oncothyreon-inc-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 18:30:05 GMT</pubDate>
    </item>
    <item>
      <title>Melanoma: Battle Of 3 Cancer Vaccines</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1362181-melanoma-battle-of-3-cancer-vaccines.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Apr 2013 13:25:30 GMT</pubDate>
    </item>
    <item>
      <title>4 Biotech Stocks Under $10 Making Big Moves</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-biotech-stocks-under-10-making-big-moves.html-0.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 09 Apr 2013 14:11:00 GMT</pubDate>
    </item>
    <item>
      <title>Oncothyreon Inc Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1273661-oncothyreon-inc-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Mar 2013 11:20:06 GMT</pubDate>
    </item>
    <item>
      <title>Oncothyreon Earnings: An Early Look</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/12/oncothyreon-earnings-an-early-look/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 12 Mar 2013 10:59:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Under $10 Set to Soar</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-under-10-set-soar.html-20.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 28 Feb 2013 13:34:00 GMT</pubDate>
    </item>
    <item>
      <title>Cancer Biotech Oncothyreon Extremely Undervalued</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1226801-cancer-biotech-oncothyreon-extremely-undervalued.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 26 Feb 2013 17:36:45 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Piper Jaffray Initiates Oncothyreon at Underweight on Pipeline Risk</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/01/3255144/update-piper-jaffray-initiates-oncothyreon-at-underweigh.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 18 Jan 2013 08:08:58 GMT</pubDate>
    </item>
    <item>
      <title>3 Pharma Stocks Leaping on Unusual Volume</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-pharma-stocks-leaping-unusual-volume.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 10 Jan 2013 14:16:00 GMT</pubDate>
    </item>
    <item>
      <title>Are Short-Sellers Onto Something at Peregrine?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/03/are-short-sellers-onto-something-at-peregrine/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 03 Jan 2013 14:06:00 GMT</pubDate>
    </item>
    <item>
      <title>Oncothyreon/Merck KGaA Drug Fails - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/89307/oncothyreon-merck-kgaa-drug-fails.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 27 Dec 2012 15:37:01 GMT</pubDate>
    </item>
  </channel>
</rss>
